0001062993-14-003497.txt : 20140530 0001062993-14-003497.hdr.sgml : 20140530 20140530172611 ACCESSION NUMBER: 0001062993-14-003497 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140528 FILED AS OF DATE: 20140530 DATE AS OF CHANGE: 20140530 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Morgan Henry CENTRAL INDEX KEY: 0001375327 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34236 FILM NUMBER: 14881452 MAIL ADDRESS: STREET 1: PO BOX 499 STREET 2: 11 DOGWOOD ROAD CITY: HOPE STATE: NJ ZIP: 07844 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2014-05-28 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC 0001375327 Morgan Henry PO BOX 499, 11 DOGWOOD ROAD HOPE NJ 07844 1 0 0 0 Common Stock, $0.001 par value 2014-05-28 4 S 0 8247 27.0268 D 48946 D Common Stock, $0.001 par value 2014-05-29 4 S 0 11753 27.0394 D 37193 D The selling price of $27.0268 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $27.00 to $27.40. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. The selling price of $27.0394 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $27.00 to $27.28. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. _/s/ Henry Morgan by Carl A. Valenstein, attorney in fact 2014-05-30